Are Larval Ticks a Hidden Threat? Insights on Borrelia Miyamotoi

Larval ticks may pose a greater risk to humans than previously recognized. Traditionally, nymphal ticks have been considered the primary threat for transmitting tick-borne diseases. However, new research suggests that larval ticks—despite their microscopic size—may also play an important role in disease transmission. :contentReference[oaicite:0]{index=0}

When ticks hatch from eggs, they enter the larval stage with only six legs. After their first blood meal, they molt into eight-legged nymphs, which are typically considered the most dangerous stage for human infection.

But emerging evidence is challenging this assumption.

---

Seasonal Clues Point to Larval Transmission

Dr. Molloy’s case series on Borrelia miyamotoi disease (BMD) found that most infections occurred in July and August—months when larval ticks are most active.

This differs from Lyme disease, which typically peaks during nymphal tick season in June and early July.

The timing suggests that larval ticks may be responsible for transmitting infection.

Researchers propose that larval ticks may acquire infection through transovarial transmission—meaning the pathogen is passed from the adult female tick directly to her offspring.

---

Rethinking the Risk of Larval Bites

Historically, larval tick bites have not been considered a significant health threat.

However, experts are now questioning that assumption:

“Bites from larval deer ticks have not been considered a health threat, but this needs to be reevaluated.”

If larval ticks can transmit infection, their small size makes them particularly concerning—because they are rarely detected during routine tick checks.

---

Challenges in Diagnosis

Diagnosing Borrelia miyamotoi disease can be difficult.

Symptoms often resemble other tick-borne illnesses, including:

• Fever
• Fatigue
• Headache
• Muscle aches

Laboratory findings may include:

• Abnormal liver enzymes
• Leukopenia
• Thrombocytopenia

Standard diagnostic tools—such as PCR, blood smear, or antibody testing—are not widely available in commercial laboratories.

This makes clinical diagnosis essential, particularly in patients with summer febrile illness and no rash.

---

Overlap With Other Tick-Borne Diseases

Dr. Molloy notes that patients presenting with a “summer fever” and positive Lyme serology may actually have:

• Borrelia burgdorferi
• Borrelia miyamotoi
• Or both infections

This overlap complicates diagnosis and may lead to underrecognition of BMD.

---

Treatment and Unknowns

Current treatment recommendations are based on limited data from acute cases.

Reported effective therapies include:

• Doxycycline and other tetracyclines
• Amoxicillin
• Cefuroxime
• Azithromycin (presumed effective)

However, long-term outcomes remain uncertain, as studies have focused primarily on acute infections.

---

Why This Matters

Emerging infections like Borrelia miyamotoi may be more common than previously recognized.

Experts suggest that infection rates may be comparable to:

• Anaplasma phagocytophilum
• Babesia microti

If larval ticks contribute to transmission, current prevention strategies may need to be reconsidered.

---

Clinical Perspective

Larval ticks may represent an underrecognized source of tick-borne infection.

Clinicians should consider Borrelia miyamotoi in patients presenting with summer febrile illness, even when tick exposure is not recalled.

Ongoing research is needed to better understand transmission dynamics, improve diagnostic tools, and clarify treatment outcomes.

---

References

1. Molloy PJ et al. Ann Intern Med, 2015.
2. Krause PJ et al. Clin Microbiol Infect, 2015.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention